IDACORP Stock Price, News & Analysis (NYSE:IDA)

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for IDACORP in the last year. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" IDA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IDA, but not buy additional shares or sell existing shares.
View IDA analyst ratings or view top-rated stocks.

4 brokerages have issued 1 year target prices for IDACORP's stock. Their IDA share price targets range from $98.00 to $108.00. On average, they anticipate the company's share price to reach $102.25 in the next twelve months. This suggests a possible upside of 3.8% from the stock's current price.
View analysts price targets for IDA or view top-rated stocks among Wall Street analysts.

IDACORP's stock was trading at $107.85 at the beginning of 2023. Since then, IDA stock has decreased by 8.7% and is now trading at $98.48.
View the best growth stocks for 2023 here.

IDACORP saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 835,400 shares, a decrease of 39.9% from the October 31st total of 1,390,000 shares. Based on an average daily volume of 347,000 shares, the short-interest ratio is currently 2.4 days. Approximately 1.7% of the company's stock are short sold.
View IDACORP's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 15th 2024.
View our IDA earnings forecast.

IDACORP, Inc. (NYSE:IDA) announced its quarterly earnings results on Thursday, November, 2nd. The energy company reported $2.07 EPS for the quarter, topping analysts' consensus estimates of $1.70 by $0.37. The energy company earned $510.91 million during the quarter, compared to the consensus estimate of $552.12 million. IDACORP had a net margin of 15.30% and a trailing twelve-month return on equity of 9.51%.

IDACORP declared a quarterly dividend on Thursday, October 19th. Investors of record on Wednesday, November 1st will be paid a dividend of $0.83 per share on Thursday, November 30th. This represents a $3.32 annualized dividend and a dividend yield of 3.37%. The ex-dividend date of this dividend is Tuesday, October 31st. This is a boost from the stock's previous quarterly dividend of $0.79.
Read our dividend analysis for IDA.

IDACORP (NYSE:IDA) pays an annual dividend of $3.32 per share and currently has a dividend yield of 3.37%. The company has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 61.94%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, IDA will have a dividend payout ratio of 61.37% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for IDA.

ETFs with the largest weight of IDACORP (NYSE:IDA) stock in their portfolio include Ecofin US Renewables Infrastructure (RNEW), First Trust EIP Carbon Impact ETF (ECLN), Invesco Dorsey Wright Utilities Momentum ETF (PUI), First Trust Utilities AlphaDEX Fund (FXU), iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV), Invesco S&P MidCap Low Volatility ETF (XMLV), First Trust North American Energy Infrastructure Fund (EMLP) and iShares U.S. Small Cap Equity Factor ETF (SMLF).

1 employees have rated IDACORP Chief Executive Officer Hal Koyama on Glassdoor.com. Hal Koyama has an approval rating of 100% among the company's employees. This puts Hal Koyama in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other IDACORP investors own include Johnson & Johnson (JNJ), AT&T (T), AbbVie (ABBV), Costco Wholesale (COST), International Business Machines (IBM), Pfizer (PFE), Procter & Gamble (PG), Walmart (WMT), Avista (AVA) and Bristol-Myers Squibb (BMY).

IDACORP's stock is owned by many different institutional and retail investors. Top institutional shareholders include Wellington Management Group LLP (2.15%), Morgan Stanley (2.06%), Victory Capital Management Inc. (1.82%), FMR LLC (1.76%), American Trust (1.64%) and River Road Asset Management LLC (1.25%). Insiders that own company stock include Jeffrey L Malmen and Mitchel D Colburn.
View institutional ownership trends.

Shares of IDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.